Transfer of bioanalytical methods across labs carries hidden risk. We lay out the decision tree for bridging studies vs. full revalidation under the new ICH framework.
This article is a seeded placeholder. Production copy will replace it prior to launch.
Careers at Vimta
Join 1,500+ scientists, engineers, and analysts solving real problems for pharma, food, and electronics companies across the world.
Our Quality team will review your responses. If anything needs follow-up, we'll get in touch within 2 working days.
